Hope on the horizon for Alzheimer’s disease


There is good news for people suffering from Alzheimer’s disease and their close relatives. American health authority FDA has just accepted the application from medication Aducanumab2 to request authorization for the American market. When started at an early stage, this medication would become the first immunotherapy with the potential to slow down neurodegeneration associated with Alzheimer’s disease.

read more

Back to posts